IMMUNO-model webinar series presents 2nd Webinar imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies

IMMUNO-model webinar series presents 2nd Webinar imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

We are pleased to invite you to the 2nd IMMUNO- model webinar entitled imSAVAR project: Nonclinical mimicking of the immune system effects of immunomodulatory therapies.

The webinar consists of two presentations and a question and answer session:

  • Katherina Sewald, Fraunhofer ITEM, Hannover Germany
    Immune-related adverse outcome pathways for regulatory decision making«
  • Marek Ostaszewski, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
    Construction, visual exploration and analytics of irAOP systems biology diagrams«

The webinar will be moderated by Christina Sakellariou, Dept. of Immunotechnology, Lund University, Lund, Sweden.

The webinar will be streamed live on the ZOOM platform on May 6th, 2024 at 2.00 – 3.30 pm CET. Description of presentations and speakers here.

Check out Webinar here.

For further information, please contact the IMMUNO-model Science Communication Coordinator Dr. Barbara Breznik (barbara.breznik@nib.si).

Latest Updates

During my two-month STSM at IPBS Toulouse, I gained hands-on experience in spectral flow cytometry and intravital microscopy for studying immune responses following electrochemotherapy. Using syngeneic mouse tumor models, we...
Grantee name: Simona Kranjc BrezarStart and end date: 1.4.2026-31.5.2026 During my two-month STSM at IPBS Toulouse, I gained hands-on experience in spectral flow cytometry and intravital microscopy for studying immune...
Conference title: ESMO Immuno-Oncology Congress 2025Conference web-page: https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2025 Conference venue: Queen Elizabeth II Centre in London, United Kingdom. Conference start and end date: 10/12/2025 to 12/12/2025 Title of the presentation:...
Training in techniques for generating patient-derived immuno-oncology models from squamous cell carcinomas I am Norbert Nass, investigator at Brandenburg Medical School (MHB), Institute of Pathology in Brandenburg / Havel, Germany....
Attending the 3R Länd Conference in Tübingen, Germany, with the support of the YRI IMMUNO-model grant was a valuable opportunity to learn about cutting-edge alternatives to animal testing and their...
In the scope of 1 month long STSM at the Science for life laboratory in Stockholm, Sweden, we combined advanced 3D glioblastoma models and different regions of glioblastoma tissue with...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter